Clinical Trial Update: Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action [Phase 4]

View source ↗

Summary

This update covers a completed Phase 4 study of teriparatide (Forteo) in postmenopausal osteoporosis. It discusses the drug's mechanism of action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Teriparatide (Forteo) (teriparatide)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED